MedTrace Logo

Super-Rehab: Can we Achieve Coronary Artery Disease Regression?

NCT05563584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-02-13

No results posted yet for this study

Summary

The Super Rehab: Can we Achieve Coronary Artery Disease Regression? (a feasibility study) proposes to test the use of a novel lifestyle intervention (Super Rehab), in addition to standard care, for patients with both coronary artery disease and metabolic syndrome. This is a feasibility study that will test study processes, enable optimisation of the intervention and provide data for power calculations to enable design of pivotal trials of the clinical effectiveness of Super Rehab.

Conditions

Interventions

BEHAVIORAL

Super Rehab

A 12-month healthcare-delivered lifestyle intervention involving exercise and nutritional support

Sponsors & Collaborators

  • University of Bath

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • University of Bristol

    collaborator OTHER

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • North Bristol NHS Trust

    collaborator OTHER

  • RUHX

    collaborator UNKNOWN

  • Royal United Hospitals Bath NHS Foundation Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-08-07
Completion
2023-08-07

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05563584 on ClinicalTrials.gov